======= PROX2 ======= == Gene Information == * **Official Symbol**: PROX2 * **Official Name**: prospero homeobox 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=283571|283571]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q3B8N5|Q3B8N5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PROX2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PROX2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615094|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcription regulator. Does not seem to be essential for embryonic development and postnatal survival (By similarity). {ECO:0000250}. |Prox1| |lens fiber cell morphogenesis| |lymphatic endothelial cell differentiation| |lymphangiogenesis| |lens fiber cell development| |lymph vessel morphogenesis| |lymph vessel development| |lens morphogenesis in camera-type eye| |lens fiber cell differentiation| |lens development in camera-type eye| |endothelial cell differentiation| |endothelium development| |camera-type eye morphogenesis| |eye morphogenesis| |epithelial cell development| |sensory organ morphogenesis| |camera-type eye development| |eye development| |visual system development| |sensory system development| |vasculature development| |cardiovascular system development| |sensory organ development| |cell morphogenesis involved in differentiation| |epithelial cell differentiation| |cell morphogenesis| |cellular component morphogenesis| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |anatomical structure formation involved in morphogenesis| |animal organ morphogenesis| |epithelium development| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|-1.84| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6687 * **Expression level (log2 read counts)**: 1.02 {{:chemogenomics:nalm6 dist.png?nolink |}}